Facial Injectables: The next frontier in on-demand beauty products
A recent report by Infinium Global Research on “Facial Injectables Market (Type – Dermal Fillers, and Anti-ageing Injections; End User – Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025” estimates that the market was worth US$ 8.00 million in 2018 and is projected to expand with a CAGR of 12.0 per cent during the period of 2019 to 2025.
Growing in popularity world over, facial injectables are becoming the next frontier in on-demand beauty products. They play an important role in anti-aging treatments and are particularly used to prevent damage like early aging and hyperpigmentation. Injectables most commonly include products such as Botox, fillers, and other elements. Botox and fillers have become the most common aesthetic procedures and are the most popular treatments among all classes of people. The easy use, temporary nature, and affordability as compared to other segments are propelling its demand in the beauty industry.
Rise in the usage of dermal fillers to augment the growth of the facial injectables market
In recent years, dermal fillers have gained worldwide acceptance and huge popularity as there is an increased demand for non-surgical aesthetic enhancement and due to the rising acceptance and adoption of the injectable cosmeceutical products among the baby boomers. Although collagen products such as Zyplast and Zyderm were the first dermal fillers to become widely available, collagen fillers have largely been replaced by Hyaluronic acid (HA) fillers. In the last few years, HA filler substances have become the new gold standard, far outpacing its usage in the other soft tissue augmentation agents. Furthermore, the new bioengineered human collagen products and the various HA fillers are all safe and effective agents for soft tissue augmentation, which increases its adoption among the consumers.
Additionally, the diminishing perception that facial aesthetics are just for women of a certain age has also increased its demand among the male population. Several publications also state that almost 25 per cent of all dermal filler treatments are now requested by male clients. As this trend continues to evolve, the demand for dermal fillers is expected to augment considerably over the forecast period.
Asia-Pacific region is rising at an unprecedented rate
As per the geographic trends, North America has held the leading position in the global facial injectables market. According to the American Society for Aesthetic Plastic Surgery, the US generated more than $1.7 billion from injectable aesthetic procedures and more than 4.5 million botulinum toxin procedures were performed in the US in 2016. In the North America region, most older people aged 65 and above in the US are women, and many are active in the workforce and therefore, represent one of the most affluent consumers of the facial injectable industry.
In the US, there are currently 15 different kinds of approved fillers. HA fillers are the highly preferred injectables in the US market as compared to permanent fillers, such as silicone, and semi-permanent ones. North America also holds the largest share in the market due to increased disposable income and high spending on grooming among the people in the US and Canada. Moreover, the increased consumption of Botox and anti-aging injections among male consumers and millennial are also influencing the growth of the North American market.
However, the Asia Pacific region is expected to grow at the fastest rate as the number of middle-aged women in the Asia-Pacific region is rising at an unprecedented rate. Furthermore, Asian countries such as China and India have many beauty conscious millennial and the Gen-Z population that drives the growth of the Asia Pacific facial injectables market. Additionally, South Korea also has a far greater percentage of the population opting for facial injectables. Moreover, increasing affordability among Asian consumers and decreasing cost of facial injectables will drive growth in the Asia Pacific facial injectables market.